Company intelligence / Profile preview

Osteo-Poretical

Ownership: Private
Employees: ~30
Development stage: Other

Overview

Osteopore is a medical technology company specializing in the development of 3D-printed bioresorbable implants for bone regeneration. The company's proprietary technology creates scaffolds that mimic the microstructure of bone, promoting natural tissue growth while the implant gradually dissolves. Their product portfolio includes solutions for craniofacial, neurosurgical, and orthopedic applications, such as the Osteoplug and Osteomesh. Based in Singapore and listed on the ASX, Osteopore focuses on improving surgical outcomes and reducing the need for permanent metal implants or autologous bone grafts.

Therapeutic areas: OtherEndocrinologyNeurologyRare DiseasesOphthalmology
Modalities: Device
Industry: Implantable Medical Devices

Partnerships

Mainz University Medical CenterNational University of SingaporeNanyang Technological University

Beyond the preview

Go deeper on Osteo-Poretical.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Osteo-Poretical.

Explore the full profile